Literature DB >> 11981368

HIV-1 and HIV-2 seroprevalence and risk factors among hospital outpatients in the Eastern Region of Ghana, West Africa.

Larry W Chang1, Muberak Osei-Kwasi, Daniel Boakye, Simeon Aidoo, Angela Hagy, James W Curran, Sten H Vermund.   

Abstract

A cross-sectional study of 854 outpatients seen at three hospitals in the Eastern Region of Ghana, West Africa assessed HIV-1 and HIV-2 seroprevalence rates and associated risk factors. During mid-1999, patients were tested in an anonymous study linked to a questionnaire and abstracted record data in three distinct communities with differing levels of urbanization. Combined HIV seroprevalence rates were 19.2% for Agomanya, the most rural community, 5.1% for Akwatia, and 3.4% for Nkawkaw, the most urbanized community. HIV-1 infection alone accounted for 84.5% of cases, compared with 9.5% and 6.0% for HIV-2 and dual infection, respectively. In a multivariable model, the Agomanya location was significantly associated with HIV status (odds ratio [OR], 7.7; 95% confidence interval [CI], 2.9-20.1; p <.0001). Employed people were also more likely to be infected (OR, 4.3; 95% CI, 1.02-18.3; p =.047). Among prenatal patients, those from Agomanya were more likely to report no live-in partner or spouse compared with Nkawkaw and Akwatia (p <.0001). These findings suggest sexual partner exchange patterns may be more useful in explaining HIV seroprevalence rates than level of community urbanization. Intervention programs directed at these high risk populations for HIV infection in Ghana are urgently needed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11981368     DOI: 10.1097/00042560-200204150-00012

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  7 in total

1.  Acceptance of Voluntary Counselling, Testing and Treatment for HIV Among Pregnant Women in Kumasi, Ghana.

Authors:  Cn Holmes; Po Preko; R Bolds; J Baidoo; Pe Jolly
Journal:  Ghana Med J       Date:  2008-03

2.  Acceptability of routine HIV counselling and testing, and HIV seroprevalence in Ugandan hospitals.

Authors:  Rhoda K Wanyenze; Cecilia Nawavvu; Alice S Namale; Bernard Mayanja; Rebecca Bunnell; Betty Abang; Gideon Amanyire; Nelson K Sewankambo; Moses R Kamya
Journal:  Bull World Health Organ       Date:  2008-04       Impact factor: 9.408

3.  Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France.

Authors:  Julia Drylewicz; Sophie Matheron; Estibaliz Lazaro; Florence Damond; Fabrice Bonnet; François Simon; François Dabis; Françoise Brun-Vezinet; Geneviève Chêne; Rodolphe Thiébaut
Journal:  AIDS       Date:  2008-02-19       Impact factor: 4.177

Review 4.  Evolution and diversity of HIV-1 in Africa--a review.

Authors:  Maria A Papathanasopoulos; Gillian M Hunt; Caroline T Tiemessen
Journal:  Virus Genes       Date:  2003       Impact factor: 2.332

5.  Early determination of human immunodeficiency virus status by routine voluntary counseling and testing in benin city, Nigeria.

Authors:  Favour Osazuwa; John Osilume Dirisu; Patrick Evbaguhita Okuonghae
Journal:  N Am J Med Sci       Date:  2012-02

Review 6.  Antiretroviral therapy response among HIV-2 infected patients: a systematic review.

Authors:  Didier K Ekouevi; Boris K Tchounga; Patrick A Coffie; Joseph Tegbe; Alexandra M Anderson; Geoffrey S Gottlieb; Marco Vitoria; François Dabis; Serge P Eholie
Journal:  BMC Infect Dis       Date:  2014-08-26       Impact factor: 3.090

7.  Evolution of the global burden of viral infections from unsafe medical injections, 2000-2010.

Authors:  Jacques Pépin; Claire Nour Abou Chakra; Eric Pépin; Vincent Nault; Louis Valiquette
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.